scholarly journals Crosstalk between Nitric Oxide and Zinc Pathways to Neuronal Cell Death Involving Mitochondrial Dysfunction and p38-Activated K+ Channels

Neuron ◽  
2004 ◽  
Vol 41 (3) ◽  
pp. 351-365 ◽  
Author(s):  
Ella Bossy-Wetzel ◽  
Maria V Talantova ◽  
Wilson D Lee ◽  
Marion N Schölzke ◽  
Anne Harrop ◽  
...  
EBioMedicine ◽  
2016 ◽  
Vol 11 ◽  
pp. 253-261 ◽  
Author(s):  
Yoshinori Mikami ◽  
Kazunori Kanemaru ◽  
Yohei Okubo ◽  
Takuya Nakaune ◽  
Junji Suzuki ◽  
...  

2005 ◽  
pp. 146-156
Author(s):  
Mika Shimoji ◽  
Valina L. Dawson ◽  
Ted M. Dawson

2018 ◽  
Vol 2018 ◽  
pp. 1-9 ◽  
Author(s):  
Jade Heejae Ko ◽  
Ju-Hee Lee ◽  
Bobin Choi ◽  
Ju-Yeon Park ◽  
Young-Won Kwon ◽  
...  

Parkinson’s disease is a neurodegenerative disease characterized by progressive cell death of dopaminergic neuron and following neurological disorders. Gagam-Sipjeondaebo-Tang (GST) is a novel herbal formula made of twelve medicinal herbs derived from Sipjeondaebo-Tang, which has been broadly used in a traditional herbal medicine. In the present study, we investigated the effects of GST against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced motor abnormalities in mice and 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in SH-SY5Y cell. First, we found that GST alleviated motor dysfunction induced by MPTP, and the result showed dopaminergic neurons recovery in substantia nigra. In the cell experiment, pretreatment with GST increased the cell viability and attenuated apoptotic cell death in MPP+-treated SH-SY5Y cells. GST also inhibited reactive oxygen species production and restored the mitochondrial membrane potential loss, which were induced by MPP+. Furthermore, GST extract significantly activated ERK and Akt, cell survival-related proteins, in SH-SY5Y cells. The effect of GST preventing mitochondrial dysfunction was antagonized by pretreatment of PD98059 and LY294002, selective inhibitors of ERK and Akt, respectively. Taken together, GST alleviated abnormal motor functions and recovered neuronal cell death, mitochondrial dysfunction, possibly via ERK and Akt activation. Therefore, we suggest that GST may be a candidate for the treatment and prevention of Parkinson’s disease.


1996 ◽  
Vol 25 ◽  
pp. S85
Author(s):  
Kunio Koshimura ◽  
Junko Tanaka ◽  
Yoshio Murakami ◽  
Yuzuru Kato

2000 ◽  
Vol 2 (1) ◽  
pp. 107-107
Author(s):  
L Tranebjaerg ◽  
S Lindal ◽  
S Merchant ◽  
O Ingebretsen ◽  
B Hamel ◽  
...  

2017 ◽  
Vol 21 (7) ◽  
pp. 520-528 ◽  
Author(s):  
Mi Hye Kim ◽  
Ju-Sik Min ◽  
Joon Yeop Lee ◽  
Unbin Chae ◽  
Eun-Ju Yang ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Howard Prentice ◽  
Jigar Pravinchandra Modi ◽  
Jang-Yen Wu

In stroke and neurodegenerative disease, neuronal excitotoxicity, caused by increased extracellular glutamate levels, is known to result in calcium overload and mitochondrial dysfunction. Mitochondrial deficits may involve a deficiency in energy supply as well as generation of high levels of oxidants which are key contributors to neuronal cell death through necrotic and apoptotic mechanisms. Excessive glutamate receptor stimulation also results in increased nitric oxide generation which can be detrimental to cells as nitric oxide interacts with superoxide to form the toxic molecule peroxynitrite. High level oxidant production elicits neuronal apoptosis through the actions of proapoptotic Bcl-2 family members resulting in mitochondrial permeability transition pore opening. In addition to apoptotic responses to severe stress, accumulation of misfolded proteins and high levels of oxidants can elicit endoplasmic reticulum (ER) stress pathways which may also contribute to induction of apoptosis. Two categories of therapeutics are discussed that impact major pro-death events that include induction of oxidants, calcium overload, and ER stress. The first category of therapeutic agent includes the amino acid taurine which prevents calcium overload and is also capable of preventing ER stress by inhibiting specific ER stress pathways. The second category involves N-methyl-D-aspartate receptor (NMDA receptor) partial antagonists illustrated by S-Methyl-N, N-diethyldithiocarbamate sulfoxide (DETC-MeSO), and memantine. DETC-MeSO is protective through preventing excitotoxicity and calcium overload and by blocking specific ER stress pathways. Another NMDA receptor partial antagonist is memantine which prevents excessive glutamate excitation but also remarkably allows maintenance of physiological neurotransmission. Targeting of these major sites of neuronal damage using pharmacological agents is discussed in terms of potential therapeutic approaches for neurological disorders.


2021 ◽  
Vol 35 (5) ◽  
Author(s):  
Rebekka Ehinger ◽  
Anna Kuret ◽  
Lucas Matt ◽  
Nadine Frank ◽  
Katharina Wild ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document